Skip to content
  • Home
  • News
    • Home
    • News

    Evora Biosciences acquires exclusive worldwide rights for digestive fistula treatment from Erganeo

    • Post published:9 avril 2020
    Lire la suite à propos de l’article Evora Biosciences acquires exclusive worldwide rights for digestive fistula treatment from Erganeo

    Erganeo and Evora Biosciences signed a world-exclusive license agreement for a breakthrough treatment of digestive fistula.

    Continuer la lectureEvora Biosciences acquires exclusive worldwide rights for digestive fistula treatment from Erganeo

    Press : press@evorabio.com

    Evora Biosciences SAS

    38 avenue Jean Moulin

    91430 Igny

    contact@evorabio.com

    Subscribe to our newsletter !

    No spam, only significant updates.
    Chargement en cours
    Copyright Evora Biosciences SAS 2023